Literature DB >> 7040966

Thrombolytic therapy.

G V Sharma, G Cella, A F Parisi, A A Sasahara.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 7040966     DOI: 10.1056/NEJM198205273062105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.

Authors:  K A Davies; P Mathieson; C G Winearls; A J Rees; M J Walport
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

2.  Association of subclavian-axillary vein thrombosis with brachial neuritis.

Authors:  C A Zahn; J J Wilson
Journal:  CMAJ       Date:  1986-07-15       Impact factor: 8.262

3.  Plasmacytosis and renal failure after readministration of streptokinase for threatened myocardial reinfarction.

Authors:  N S Chan; H White; A Maslowski; J Cleland
Journal:  BMJ       Date:  1988-09-17

4.  Selective thrombolysis with low-dose urokinase in chronic arteriosclerotic obstructions.

Authors:  L Lupattelli; F Barzi; P Corneli; A Lemmi; S Mosca
Journal:  Cardiovasc Intervent Radiol       Date:  1988-06       Impact factor: 2.740

Review 5.  Drug interactions with thrombolytic agents. Current perspectives.

Authors:  A de Boer; J M van Griensven
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

6.  Subclavian-axillary vein thrombosis: successful treatment with streptokinase.

Authors:  J J Wilson; D Lesk; H Newman
Journal:  Can Med Assoc J       Date:  1984-04-01       Impact factor: 8.262

7.  Streptokinase induced defibrination assessed by thrombin time: effects on residual coronary stenosis and left ventricular ejection fraction.

Authors:  K Ranjadayalan; R Stevenson; B Marchant; V Umachandran; S W Davies; D Syndercombe-Court; C N Gutteridge; A D Timmis
Journal:  Br Heart J       Date:  1992-08

8.  Immunology of streptokinase in human subjects.

Authors:  K McGrath; R Patterson
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

9.  Streptokinase for aortic thrombosis.

Authors:  C R Kirk; C N Bhrolchain; S A Qureshi
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

Review 10.  Thrombolytic therapy in the treatment of stroke.

Authors:  G J del Zoppo
Journal:  Drugs       Date:  1997       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.